However, as anticipated with a short biological half-life secondary to rapid phase II metabolism and poor bioavailability [97], raloxifene is not superior to tamoxifen at equivalent doses [95]. Raloxifene maintains bone density in ovariectomised rats 29, 98, 99, 100, 101, 102, 103. In ...